Global Fund reports success of latest HIV, TB and malaria investments:
This article was originally published in Clinica
Executive Summary
The direct investments associated with around 400 grants for HIV/AIDS, TB and malaria programmes have resulted in unprecedented improvements in performance. So announced the Global Fund yesterday, during a United Nations meeting that is being held this week in New York to discuss progress in these areas of care. Over the last six months, 1.4 million people (up 43% since December 2005) are reportedly being treated for TB under the WHO's gold-standard DOTS programme, and 544,000 more people (up 42%) are receiving antiretroviral treatment for HIV/AIDS.